Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

These 2 Growth Stocks Have Potential Catalysts on the Way

TheMotleyFool

0 0

These 2 Growth Stocks Have Potential Catalysts on the Way: https://g.foolcdn.com/editorial/images/704123/doctor-and-patient-talking.jpg

Fortunes can change quickly in the volatile biotech industry. And few things can impact drugmakers' performance -- and prospects -- the way regulatory approvals can. That's why it's a good idea for biotech investors to keep an eye on upcoming regulatory decisions.

With that as a backdrop, let's look at two companies that could land green lights from regulators in the U.S. before the end of the year: Gilead Sciences (NASDAQ: GILD) and Provention Bio (NASDAQ: PRVB).